コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 drome (RDS) is the commonest diagnosis after premature birth.
2 cal for impaired cognitive performance after premature birth.
3 ular haemorrhage is a common complication of premature birth.
4 Maternal ILI may have triggered premature birth.
5 cal factors associated with brain injury and premature birth.
6 ovel therapeutic target for the treatment of premature birth.
7 adulthood phenotypes previously linked with premature birth.
8 elivery offering new prototypes for delaying premature birth.
9 ing cause of neurological deficits following premature birth.
10 ory response, and is closely associated with premature birth.
11 d treatment of lung diseases associated with premature birth.
12 e important players in regulating subsequent premature birth.
13 the neonatal lung parenchyma associated with premature birth.
14 glucocorticoid therapies for lung defects in premature birth.
15 most common causes of death associated with premature birth.
16 tors, which in turn may cause miscarriage or premature birth.
17 erized by a thick desquamating epidermis and premature birth.
18 ociation does not seem to be associated with premature birth.
19 y dysplasia (BPD) is a major complication of premature birth.
20 tricular white matter injury in survivors of premature birth.
21 neurodevelopmental morbidity in survivors of premature birth.
22 in the occurrence of other complications of premature birth.
23 d to fetal growth restriction rather than to premature birth.
24 pmental disorders and other complications of premature birth.
25 Is) are associated with approximately 27% of premature births.
26 associated with adults' anxiety traits after premature birth?
28 61; 95% confidence interval [CI], 8.5-18.5), premature birth (46.0%, RR = 11.32; 95% CI, 8.1-15.7) an
30 oxin in placental blood were associated with premature birth, acute chorioamnionitis, and elevated pr
32 set of their rheumatic disease, particularly premature births (also seen in RA women after disease on
33 ty lupus during pregnancy leads to increased premature birth and a decrease in live births, with almo
34 fications because of the association between premature birth and accompanying hypoxia, and increased
36 d no underlying medical conditions, although premature birth and asthma were more frequent among hosp
37 tal NTHi disease is strongly associated with premature birth and causes significant morbidity and mor
38 s aspects of impaired neurodevelopment after premature birth and lead to reduced cognitive performanc
39 humans that cBF integrity is impaired after premature birth and links neonatal complications with lo
41 mnionitis places the fetus at higher risk of premature birth and may increase the risk of neurodevelo
42 pe 1 (HIV-1) infection increases the risk of premature birth and other adverse outcomes of pregnancy.
44 ge in the motor impairment that results from premature birth and suggest that therapies designed to p
45 quadriplegic cerebral palsy associated with premature birth and typical periventricular leukomalacia
46 a (e.g., asthma, cardiovascular diseases, or premature birth) and who were younger than two years of
47 sion in pregnancy, fetal growth restriction, premature birth, and fetal and maternal mortality (1).
48 kinase levels, rates of congenital anomaly, premature birth, and growth parameters in infants were c
49 treated HIV with 3 pregnancy outcomes: loss, premature birth, and low birth weight and factors associ
51 uding fulminant hepatic failure, fetal loss, premature birth, and neonatal mortality, although the un
53 sk factor for fetal loss, preeclampsia (PE), premature birth, and the occurrence of any placenta-medi
54 ration trajectories, including the effect of premature birth, and to translate cortical atlases betwe
56 h NAFLD, with a significant direct effect of premature birth, and without an indirect effect of low B
57 /ethnicity, glomerular status, birth weight, premature birth, angiotensin-converting enzyme inhibitor
60 t lower FD partly underpins FA reductions of premature birth but that other processes such as hypomye
61 of respiratory distress syndrome (RDS) after premature birth by altering vasoreactivity and increasin
63 magnesium sulfate, administered soon before premature birth, can reduce the high rate of cerebral pa
64 urity is a sight-threatening complication of premature birth caused by nitro-oxidative insult to the
66 t known whether the stresses associated with premature birth disrupt regionally specific brain matura
67 al and experimental studies demonstrate that premature birth disrupts alveolarization, decreasing the
72 ns included primiparity in 8 patients (42%), premature birth in 6 (32%), and maternal diabetes mellit
73 second half of pregnancy was associated with premature birth in 8 of 28 cases (28.6%; 95% CI, 13.2%-4
76 igravidae (OR, 6.09; 95% CI, 1.16-31.95) and premature births in multigravidae (OR, 2.25; 95% CI, 1.1
77 (ROP) affects only premature infants, but as premature births increase in many areas of the world, RO
78 ausal mediation analysis showed that earlier premature birth indirectly mediated 25% of the associati
81 al lipid species early in the progression to premature birth is an important step toward discovering
89 Overall, these results provide evidence that premature birth leads to permanently aberrant gyrificati
92 pregnancy, the higher the incidence of very premature birth (<34 weeks) and severe small for gestati
93 (1) a genetic or neurological condition, (2) premature birth (<37 weeks), and (3) current participati
94 perienced a pregnancy loss, 169/1725 (10%) a premature birth (<37 weeks), and 74/1317 (6%) had a low-
95 for Congenital Heart Surgery risk category, premature birth, major noncardiac structural anomaly, an
98 natal disorders, injuries, mental disorders, premature birth, musculoskeletal disorders, congenital b
103 effects of neonatal hypoxia associated with premature birth on the central nervous system are well k
104 iation analysis was used to evaluate whether premature birth or birth GA would mediate the associatio
105 y and mortality in the infant as a result of premature births or genetic or drug-induced NMDA recepto
107 R, 0.37; 95% CI, 0.19-0.75; P < .001), fewer premature births (OR, 0.44; 95% CI, 0.24-0.79; P < .01),
108 rclage due to a history of pregnancy loss or premature birth, or if indicated by ultrasound, were cen
109 owth in the neonatal period inevitable after premature birth, or is it associated with specific medic
112 ay, 53 toddlers with other conditions [e.g., premature birth, prenatal drug exposure], 64 toddlers wi
115 prematurity syndrome (IPS), characterized by premature birth, respiratory distress, and edematous ski
117 tic cohort, children who had had an LBW or a premature birth showed the greatest responses to ozone.
118 erences in the overall rates of miscarriage, premature births, small full-term births, or neonatal de
119 mes, including the frequency of miscarriage, premature births, small full-term infants, perinatal dea
120 nominator for postnatal phenomena related to premature birth, such as neonatal mortality and cerebral
121 crostructure is vulnerable to the effects of premature birth, suggesting a mechanism for the adverse
123 approximately 4 days), detects signatures of premature birth that are not captured by brain size, is
124 chronic respiratory disease associated with premature birth that primarily affects infants born at l
125 isability and cerebral palsy in survivors of premature birth, the cellular-molecular mechanisms by wh
126 orly characterized pulmonary complication of premature birth; the current definition is based solely
127 infections predispose low birth weights and premature birth, then such outcomes should be apparent w
128 ted with many negative health outcomes, from premature birth to sudden infant death syndrome and adve
129 ciation between family history of asthma and premature birth was found, but it was not associated wit
132 h-club organization remains intact following premature birth, we reveal significant disruptions in bo
137 l the end of pregnancy, we hypothesized that premature birth would disrupt interneuron production and